A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate cancer will benefit from adding hormone therapy to radiation after surgery - the ...
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced a ...
Scientists at the MRC Laboratory of Medical Sciences (LMS) have discovered a DNA-based “dimmer switch” that regulates the activity of a critical developmental gene, Cdx2. This work could pave the way ...
As gene therapies continue to advance, the demand for scalable, reproducible, and efficient potency assays is rapidly increasing—especially for adeno-associated virus (AAV) vectors. Accurate ...
In a recent study published in the journal Nature Biotechnology, researchers describe the pA regulator system based on a ribonucleic acid (RNA)-based switch to regulate mammalian gene expression by ...
Recent estimates of chronic pain prevalence in the United States indicate that more than 50 million adults (20.5 percent) report experiencing pain on most days or every day (Yong, Mullins, and ...
Seasoned Executive Brings Three Decades of Oncology and Cell Therapy Leadership from Pfizer, Novartis, and Bayer ATLANTA, Dec. 10, 2025 /PRNewswire/ -- Expression Therapeutics, Inc., a clinical-stage ...
Once limited to nonspecific anti-inflammatory therapies, expanding treatment options for atopic dermatitis are allowing therapy to be individualized.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback